GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.450
+0.090 (3.81%)
At close: Apr 10, 2026, 4:00 PM EDT
2.340
-0.110 (-4.49%)
After-hours: Apr 10, 2026, 7:39 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.54 million as of April 10, 2026. Its market cap has increased by 13.26% in one year.
Market Cap
3.54M
Enterprise Value
-4.62M
1-Year Change
13.26%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.54M, a decrease of -86.00%. That is a compound annual growth rate of -48.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 3.54M | 41.73% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 4.22M |
| Indaptus Therapeutics | 4.15M |
| VivoSim Labs | 3.99M |
| Enveric Biosciences | 3.85M |
| Azitra | 3.79M |
| Silexion Therapeutics | 3.70M |
| Alzamend Neuro | 3.43M |
| Matinas BioPharma Holdings | 3.23M |